Amyris Publishes ESG Report and Sets ESG Impact Goals
With its leading Lab-to-Market™ science and technology, Amyris translates biotechnology into new applications and products that are better for people and the planet.
With its leading Lab-to-Market™ science and technology, Amyris translates biotechnology into new applications and products that are better for people and the planet. Through the development and commercialization of sustainably-sourced molecules Amyris enables a transition to sustainable ingredients for the beauty, health and wellness sectors. Their inaugural ESG report communicates the company's progress and baseline for measurement of its ESG impact goals, which includes becoming net zero by 2030, reaching 100% engagement in community improvement by 2024, and confirming 100% of Amyris partners adopt the Amyris "Partnership Pledge to the Planet" by 2023.
Read the full article here.
